Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease

BACKGROUND: Lysophosphatidic acids (LPAs) are bioactive signaling phospholipids that have been implicated in Alzheimer’s disease (AD). It is largely unknown whether LPAs are associated with AD pathology and progression from mild cognitive impairment (MCI) to AD. METHODS: The current study was perfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Shahzad, Orellana, Adelina, Kohler, Isabelle, Frölich, Lutz, de Rojas, Itziar, Gil, Silvia, Boada, Mercè, Hernández, Isabel, Hausner, Lucrezia, Bakker, Margot H. M., Cabrera-Socorro, Alfredo, Amin, Najaf, Ramírez, Alfredo, Ruiz, Agustín, Hankemeier, Thomas, Van Duijn, Cornelia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532619/
https://www.ncbi.nlm.nih.gov/pubmed/33008436
http://dx.doi.org/10.1186/s13195-020-00680-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532619/
https://www.ncbi.nlm.nih.gov/pubmed/33008436
http://dx.doi.org/10.1186/s13195-020-00680-9

Ejemplares similares